BioNTech SE Sponsored ADR (BNTX) vs Exelixis, Inc. (EXEL)
- BioNTech SE Sponsored ADR BNTX 87.57 −2.92%
- Exelixis, Inc. EXEL 62.11 −1.15%
BioNTech SE Sponsored ADR and Exelixis, Inc. are both Biotechnology companies. BioNTech SE Sponsored ADR is the larger, with a market value of $22.7B against $15.6B — 1.5× the size. BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Exelixis, Inc. trades at 18.8×. Exelixis, Inc. grew revenue faster over the last twelve months: 9.23% against −3.33%. Exelixis, Inc. has the higher net margin (35.3% vs −65.8%) and the higher return on invested capital (60.5% vs −38.4%). Across the 20 metrics below, Exelixis, Inc. leads on 16 and BioNTech SE Sponsored ADR on 4.
Valuation
Profitability
| Metric | BNTX | EXEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.24% | 96.48% | 65.16% |
| Operating margin | (77.94%) | 39.88% | 0.00% |
| Net margin | (65.75%) | 35.33% | 0.00% |
| Free cash flow margin | 16.58% | 47.55% | 0.00% |
| Return on equity | (9.53%) | 44.39% | (56.36%) |
| Return on assets | (8.24%) | 33.28% | (48.04%) |
| Return on invested capital | (38.39%) | 60.45% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack